ZPHC Anastrozole 1mg

Anastrozole ZPHC — 1 mg (100 tablets × 1 mg)

ZPHC Anastrozole 1mg is an orally active, non-steroidal Type II Aromatase Inhibitor (AI) formulated with 1mg of Anastrozole as its active pharmaceutical ingredient. The molecule exerts its pharmacological effect by selectively and competitively binding to the heme group of the cytochrome P450 aromatase ($CYP19A1$) enzyme, preventing the peripheral enzymatic conversion of circulating androgens (testosterone and androstenedione) into estrogens (estradiol and estrone).

By suppressing circulating baseline serum estrogen levels by approximately 80% at standard doses, Anastrozole limits estrogen-receptor activation in target tissues without disrupting adrenal glucocorticoid or mineralocorticoid production.

Manufactured by Zhengzhou Pharmaceutical Co., Ltd. (ZPHC) under cGMP standards and verified by batch testing protocols to ensure content uniformity and active purity. Store at controlled room temperature (15°C to 25°C), shielded from direct sunlight, thermal variation, and ambient moisture.

Product Attribute Table

Attribute	Specification
Manufacturer / Brand	ZPHC (Zhengzhou Pharmaceutical Co., Ltd.)
Product Name	Anastrozole
Active Substance	Anastrozole (Arimidex)
Chemical Name	2,2′-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
Dosage / Concentration	1 mg/tablet
Form	Oral Tablet
Compound Category	Type II Non-Steroidal Aromatase Inhibitor
Storage Requirements	Controlled Room Temperature (15°C – 25°C), Protect from direct light and moisture